{"id":4623,"date":"2016-02-24T17:20:31","date_gmt":"2016-02-24T17:20:31","guid":{"rendered":"https:\/\/cbisonline.com\/us\/?post_type=cri_updates&#038;p=4623"},"modified":"2021-12-03T10:26:51","modified_gmt":"2021-12-03T10:26:51","slug":"gilead-sciences","status":"publish","type":"cri_updates","link":"https:\/\/cbisonline.com\/us\/cri_updates\/gilead-sciences\/","title":{"rendered":"Gilead Sciences"},"content":{"rendered":"<p>CBIS began its engagement with Gilead Sciences on the issue of access to health for the world\u2019s poor in 2016. CBIS has already met with the access to Medicine Foundation to discuss ways Gilead and the pharmaceutical industry can help the world\u2019s poorest people access the medicine they need. Pharmaceutical companies have an important role to play by responding with concrete, effective action to combat diseases that disproportionately affect the poor and vulnerable. Expanding the supply of life-saving medications can help meet an urgent public health need in low-income countries. Gilead produces and has improved access to medications in developing countries for HIV, hepatitis, and disease caused by parasites. CBIS will work with Gilead to ensure the company is evaluating reduced pricing options to expand coverage for patients, coordinating and supporting education for medical and clinical workers, and expanding innovative patent agreements to hepatitis therapies.<\/p>\n<p>In the first quarter of 2017, CBIS and other shareholders&nbsp;had a call&nbsp;in April to discuss Gilead\u2019s new focus:<\/p>\n<ul>\n<li><span class=\"font-bold text-endeavour\">Market expansion:<\/span> To tackle the Hepatitis C crisis, Gilead will build new manufacturing plants in China&nbsp;where 10 million people are infected. Gilead hopes to replace outdated medications with poor cure rates.<\/li>\n<li><span class=\"font-bold text-endeavour\">Pilot projects:<\/span>&nbsp;Gilead donated drugs to the government of Georgia, the country with the world&#8217;s third highest prevalence of hepatitis C. The goal is a 90% reduction in prevalence by 2020.<\/li>\n<li><span class=\"font-bold text-endeavour\">Global frameworks:<\/span> The company committed to meet the UN Sustainable Development Goal of ensuring healthy lives and well-being worldwide by 2030, a positive step.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>CBIS began its engagement with Gilead Sciences on the issue of access to health for the world\u2019s poor in 2016. CBIS has already met with the access to Medicine Foundation to discuss ways Gilead and the pharmaceutical industry can help the world\u2019s poorest people access the medicine they need. Pharmaceutical companies have an important role [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":0,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"issues":[7,8],"class_list":["post-4623","cri_updates","type-cri_updates","status-publish","hentry","issues-access-to-health-and-nutrition","issues-economic-justice"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Gilead Sciences | CBIS | Catholic Socially Responsible Investment Solutions<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gilead Sciences | CBIS | Catholic Socially Responsible Investment Solutions\" \/>\n<meta property=\"og:description\" content=\"CBIS began its engagement with Gilead Sciences on the issue of access to health for the world\u2019s poor in 2016. CBIS has already met with the access to Medicine Foundation to discuss ways Gilead and the pharmaceutical industry can help the world\u2019s poorest people access the medicine they need. Pharmaceutical companies have an important role [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cbisonline.com\/us\/cri_updates\/gilead-sciences\/\" \/>\n<meta property=\"og:site_name\" content=\"CBIS | Catholic Socially Responsible Investment Solutions\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CBISSocial\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-03T10:26:51+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cbisonline\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cbisonline.com\\\/us\\\/cri_updates\\\/gilead-sciences\\\/\",\"url\":\"https:\\\/\\\/cbisonline.com\\\/us\\\/cri_updates\\\/gilead-sciences\\\/\",\"name\":\"Gilead Sciences | CBIS | Catholic Socially Responsible Investment Solutions\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cbisonline.com\\\/us\\\/#website\"},\"datePublished\":\"2016-02-24T17:20:31+00:00\",\"dateModified\":\"2021-12-03T10:26:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cbisonline.com\\\/us\\\/cri_updates\\\/gilead-sciences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cbisonline.com\\\/us\\\/cri_updates\\\/gilead-sciences\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cbisonline.com\\\/us\\\/cri_updates\\\/gilead-sciences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cbisonline.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gilead Sciences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cbisonline.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/cbisonline.com\\\/us\\\/\",\"name\":\"CBIS | Catholic Socially Responsible Investment Solutions\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/cbisonline.com\\\/us\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cbisonline.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cbisonline.com\\\/us\\\/#organization\",\"name\":\"CBIS | Catholic Socially Responsible Investment Solutions\",\"url\":\"https:\\\/\\\/cbisonline.com\\\/us\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cbisonline.com\\\/us\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cbisonline.com\\\/us\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2021\\\/10\\\/logo.svg\",\"contentUrl\":\"https:\\\/\\\/cbisonline.com\\\/us\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2021\\\/10\\\/logo.svg\",\"width\":287,\"height\":91,\"caption\":\"CBIS | Catholic Socially Responsible Investment Solutions\"},\"image\":{\"@id\":\"https:\\\/\\\/cbisonline.com\\\/us\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/CBISSocial\",\"https:\\\/\\\/x.com\\\/cbisonline\",\"http:\\\/\\\/www.linkedin.com\\\/company\\\/christian-brothers-investment-services\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gilead Sciences | CBIS | Catholic Socially Responsible Investment Solutions","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"Gilead Sciences | CBIS | Catholic Socially Responsible Investment Solutions","og_description":"CBIS began its engagement with Gilead Sciences on the issue of access to health for the world\u2019s poor in 2016. CBIS has already met with the access to Medicine Foundation to discuss ways Gilead and the pharmaceutical industry can help the world\u2019s poorest people access the medicine they need. Pharmaceutical companies have an important role [&hellip;]","og_url":"https:\/\/cbisonline.com\/us\/cri_updates\/gilead-sciences\/","og_site_name":"CBIS | Catholic Socially Responsible Investment Solutions","article_publisher":"https:\/\/www.facebook.com\/CBISSocial","article_modified_time":"2021-12-03T10:26:51+00:00","twitter_card":"summary_large_image","twitter_site":"@cbisonline","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cbisonline.com\/us\/cri_updates\/gilead-sciences\/","url":"https:\/\/cbisonline.com\/us\/cri_updates\/gilead-sciences\/","name":"Gilead Sciences | CBIS | Catholic Socially Responsible Investment Solutions","isPartOf":{"@id":"https:\/\/cbisonline.com\/us\/#website"},"datePublished":"2016-02-24T17:20:31+00:00","dateModified":"2021-12-03T10:26:51+00:00","breadcrumb":{"@id":"https:\/\/cbisonline.com\/us\/cri_updates\/gilead-sciences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cbisonline.com\/us\/cri_updates\/gilead-sciences\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/cbisonline.com\/us\/cri_updates\/gilead-sciences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cbisonline.com\/us\/"},{"@type":"ListItem","position":2,"name":"Gilead Sciences"}]},{"@type":"WebSite","@id":"https:\/\/cbisonline.com\/us\/#website","url":"https:\/\/cbisonline.com\/us\/","name":"CBIS | Catholic Socially Responsible Investment Solutions","description":"","publisher":{"@id":"https:\/\/cbisonline.com\/us\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cbisonline.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cbisonline.com\/us\/#organization","name":"CBIS | Catholic Socially Responsible Investment Solutions","url":"https:\/\/cbisonline.com\/us\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cbisonline.com\/us\/#\/schema\/logo\/image\/","url":"https:\/\/cbisonline.com\/us\/wp-content\/uploads\/sites\/2\/2021\/10\/logo.svg","contentUrl":"https:\/\/cbisonline.com\/us\/wp-content\/uploads\/sites\/2\/2021\/10\/logo.svg","width":287,"height":91,"caption":"CBIS | Catholic Socially Responsible Investment Solutions"},"image":{"@id":"https:\/\/cbisonline.com\/us\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CBISSocial","https:\/\/x.com\/cbisonline","http:\/\/www.linkedin.com\/company\/christian-brothers-investment-services"]}]}},"_links":{"self":[{"href":"https:\/\/cbisonline.com\/us\/wp-json\/wp\/v2\/cri_updates\/4623","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cbisonline.com\/us\/wp-json\/wp\/v2\/cri_updates"}],"about":[{"href":"https:\/\/cbisonline.com\/us\/wp-json\/wp\/v2\/types\/cri_updates"}],"author":[{"embeddable":true,"href":"https:\/\/cbisonline.com\/us\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/cbisonline.com\/us\/wp-json\/wp\/v2\/comments?post=4623"}],"version-history":[{"count":0,"href":"https:\/\/cbisonline.com\/us\/wp-json\/wp\/v2\/cri_updates\/4623\/revisions"}],"wp:attachment":[{"href":"https:\/\/cbisonline.com\/us\/wp-json\/wp\/v2\/media?parent=4623"}],"wp:term":[{"taxonomy":"issues","embeddable":true,"href":"https:\/\/cbisonline.com\/us\/wp-json\/wp\/v2\/issues?post=4623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}